https://scholars.lib.ntu.edu.tw/handle/123456789/627856
標題: | Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate - An example of breast cancer | 作者: | Huang, Shu-Wei Sun, Ming-Tsung Lee, Wen-Sen Su, Ying-Shih Lee, Yi-Tzu Chiang, Ming-Hsien Wang, Yung-Chih Yang, Ya-Sung Tzeng, Shian-Chiuan Wu, Tien-Yuan Sun, Jui-Sheng Lin, Feng-Huei |
關鍵字: | Breast cancer; Combination therapy; Pyrvinium pamoate; Tigecycline | 公開日期: | 二月-2022 | 出版社: | ELSEVIER TAIWAN | 卷: | 55 | 期: | 1 | 起(迄)頁: | 51 | 來源出版物: | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 摘要: | Tigecycline is an antibiotic that well tolerated for treating complicated infections. It has received attention as an anti-cancer agent and expected to solve two major obstacles, sides effects that accompany chemotherapy and drug resistance, in the breast cancer treatment. However, previous studies reported that the levels in the blood are typically low of tigecycline, so higher doses are needed to treat cancer, that may increase the risk of side effects. To achieve better anti-cancer effects for tigecycline, we need to find a novel adjunct agent. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627856 | ISSN: | 1684-1182 | DOI: | 10.1016/j.jmii.2020.12.008 |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。